Top

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Published in:

Open Access 01-12-2021 | Addiction | Research

Does type and number of used substances affect the severity of illness in patients with substance use disorders?

Authors: Maha Ali Hassan, Mohamed Ayman Abdelhameed, Mostafa Mahmoud Abd El-Naem, Mohamed Helmy Abdelhafeez

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2021

Abstract

Background

Substance use disorders (SUD) are considered as serious mental illnesses, with variability of age of onset, duration of illness, and type of used substance among patients. The effect of type and number of substances used on the severity of such an illness are worth scientific investigation.

In this study, we tried to investigate the probable relationship between type and number of used substances with the degree of severity of substance used disorders in a sample of upper Egyptian patients. To predict risk factors associated with the severity of SUD.

Results

Opiates (including tramadol) were the most frequently used substances followed by cannabis and then heroin. Patients using poly substances scored significantly higher than the ones using a single substance on AIS (p = 0.001), as well as on the legal, drug, and family and social subscales of ASI (0.012 0.006, 0.002 respectively). Multiple stepwise linear regression analysis demonstrated that the number of used substances was the most prominent factor in determining severity of substance-related disorder.

Conclusions

Using more than one substance is common in patients with substance use disorders. This is usually associated in more severe form and consequences of illness. So, some substances and combinations are associated with more morbidity than others.

Sdrulla AD, Chen G, Mauer K. Definition and demographics of addiction. In: Kaye A, Vadivelu URD, editors. Substance abuse inpatient and outpatient management for every clinician. New York: Springer; 2015. p. 1–17.

Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitzation view. Addiction. 2000;95:91–11.

Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr. Opin. Neurobiol. 2001;11(2):250–7. https://doi.org/10.1016/S0959-4388(00)00204-X.CrossRefPubMed

Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005;8(11):1458–63. https://doi.org/10.1038/nn1584.CrossRefPubMed

Salem SS, Wahab MA, Shaheen MO, Husin NM. Cognitive impairment among drug abuser. An Egyptian study, Cairo University; 2003.

Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence. J Subst Abuse. 1998;10(2):163–73. https://doi.org/10.1016/S0899-3289(99)80131-X.CrossRefPubMed

Lynskey MT, Health AC, Bucholz KK, Slutskey WS, Madden PA, Nelson EC, et al. Escalation of drug use in early onset cannabis users vs. co-twin controls. JAMA. 2003;289(4):427–33. https://doi.org/10.1001/jama.289.4.427.CrossRefPubMed

Khalil A, Okasha T, Mansour SM, Haroon A, El Habiby M, Carise D. Characterization of substance abuse patients presenting for treatment at a University Psychiatric Hospital in Cairo, Egypt. Addict Disord Their Treat. 2008;8:199–209.CrossRef

Mohamed NR, Hammad SA, El Hamrawy LG, Rajab AZ, El Bahy MS, Soltan MR. Dual diagnosis and psychosocial correlates in substance abuse in Menoufia, Egypt. Menoufia Med. J. 2013;26:114–21.CrossRef

10.

El-Awady SA, El sheshtawy EA, El bahaey WA, El boraie OA. Impact of familial risk factors on the severity of addiction in a sample of Egyptian adolescents. Egypt J Psychiatr. 2017;38(2):70–8. https://doi.org/10.4103/1110-1105.209677.CrossRef

11.

Alvarez-Alonso MJ, Jurado-Barba R, Martinez-Martind N, Espin-Jaime JC, Jimenez-Arriero J, Manzanares G. Association between maltreatment and polydrug use among Adolescents. Child Abuse Negl. 2016;51:379–89. https://doi.org/10.1016/j.chiabu.2015.07.014.CrossRefPubMed

12.

Raes V, Maeyer JD, Vanderplasschen W, Lammertyn J. Poly substance use, mental health and related problems among persons seeking treatment in De Sleutel. In: Vanderplasschen W, Maeyer JD, Colpaert K, Cogels S, Rea A, Broekaert E, editors. Poly substance use and mental health among individuals presenting for substance abuse treatment. Europe: Academia press; 2011. p. 91–110.

13.

Schrimsher GW, Parker JD, Burke RS. Relation between cognitive testing performance and pattern of substance use in males at treatment entry. Clin Neuropsychol. 2007;21(3):498–510. https://doi.org/10.1080/13803390600674441.CrossRefPubMed

14.

Lin LA, ASB B, Blow FC, Gordon AJ, Ignacio RV, Kim HM, et al. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction. 2021;116,1:96–104.CrossRef

15.

World Health Organization. International statistical classification of diseases and related health problems, 10th edition (ICD10). Geneva: Vol.1. 1995.

16.

McLellan AT, Lubrosky L, Woody GE, Brien CP. An improved diagnostic evaluation instrument for substance abuse patients, The Addiction Severity Index. J Nerv Ment Dis. 1980;168(1):26–33. https://doi.org/10.1097/00005053-198001000-00006.CrossRefPubMed

17.

Hodgings DC, El-Guebaly N, Armstrong S, Dufour M. Implications of depression on the outcome of alcohol dependence: 3 years prospective,Alcohol Clin Exp Res.1999;23(1):151–7.

18.

McLellan AT, Lubrosky L, Cacciola J, Griffith J, Evans F. New data from Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis. 1985;173(7):412–23. https://doi.org/10.1097/00005053-198507000-00005.CrossRefPubMed

19.

Baker TB, Morse E, Sherman JE. The motivation to use drugs: a psychobiological analysis of urges. In: Rivers C, editor. The Nebraska Symposium on Motivation: alcohol use and abuse. Lincoln: University of Nebraska Press; 1987. p. 257–323.

20.

Statistical Package of Social Sciences (SPSS) Version 15.0 for Windows Chicago: SPSS Inc.,; 60606-6412. 2006.

21.

Abd El-Azim KA. Psychosocial correlates of substance abuse (a study in an Egyptian sample). Unpublished MD thesis. Faculty of Medicine, Ain Shams University; 2001.

22.

Abou Khatwa S, Kamel F, Youssef R, Attia M, Fawal K. Epidemiological study of addicts admitted to Maamoura psychiatric hospital in Alexandria. J Egypt Public Health Assoc. 1997;22:88–112.

23.

Mohamed NR, El Hamrawy LG, Shalaby AS, El Bahy MS, Abd Allah MM. An epidemiological study of tramadol HCl dependence in an outpatient addiction clinic at Heliopolis Psychiatric Hospital. Menoufia Med. J. 2015;28:591–6.CrossRef

24.

Eid H. Substance dependence in a sample of Egyptian adolescents. Unpublished MD Thesis. Faculty of Medicine, Cairo University; 2006.

25.

Mikhail M, Eissa MA, Labeeb SHA, El-Hamid SM. The Psychosocial Aspects of Drug Addicts in Assiut Governorate. Bull. Environ. Stud. 2001;4:33–44.

26.

Okasha A. Substance use in a major public health hazard. Proceedings of the First Egyptian International Conference on Addiction and Drug Abuse. Cairo: Ministry of Health; 1997.

27.

Hatata HA. Dual diagnosis in substance use disorders. Unpublished MD thesis. Faculty of Medicine, Ain Shams University; 2004.

28.

Olson VG, Heusner CL, Bland RJ, During MJ, Weinshenker D, Palmiter RD. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science. 2006;311(5763):1017–20. https://doi.org/10.1126/science.1119311.CrossRefPubMed

Title: Does type and number of used substances affect the severity of illness in patients with substance use disorders?
Authors: Maha Ali Hassan
Mohamed Ayman Abdelhameed
Mostafa Mahmoud Abd El-Naem
Mohamed Helmy Abdelhafeez
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keywords: Addiction
Addiction
Tramadol
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery / Issue 1/2021
Electronic ISSN: 1687-8329
DOI: https://doi.org/10.1186/s41983-021-00361-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Does type and number of used substances affect the severity of illness in patients with substance use disorders?

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Role of some inflammatory biomarkers in prediction of short-term outcome in acute ischemic stroke

Multidisciplinary management of juvenile nasopharyngeal angiofibroma

A review on SARS-CoV-2 and stroke pathogenesis and outcome

Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review

A case report of isolated abducens nerve palsy: idiopathic or ophthalmoplegic neuropathy?

Right to left shunting detection by contrast-enhanced transcranial color-coded duplex among patients with cryptogenic stroke